# Abbott Laboratories (ABT) — Q2-2017 Earnings Results

**Report date:** 2017-07-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q2-2017

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Up 2.87%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +0.76% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS performance, highlighting their commitment to innovation. They did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS results this quarter.

> Our focus remains on delivering innovative products to the market.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Abbott Labs reported a positive surprise in EPS, which contributed to a 2.87% increase in stock price. The lack of revenue data and guidance may leave investors cautious, but the management's focus on innovation suggests a commitment to growth. Overall, the earnings report indicates a solid performance in the current quarter.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q2-2017_